Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Gallistl, S; Cvirn, G; Leschnik, B; Muntean, W.
Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA.
Blood Coagul Fibrinolysis. 2002; 13(7):653-655 Doi: 10.1097%2F00001721-200210000-00012
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Führende Autor*innen der Med Uni Graz
Gallistl Siegfried
Co-Autor*innen der Med Uni Graz
Cvirn Gerhard
Leschnik Bettina
Muntean Eugen
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Activated prothrombin complex concentrates (APCCs) are effective in the therapy of bleeding episodes in hemophilic patients with inhibitors. We investigated the respective roles of factor II, factor VII, factor IX, and factor X in the procoagulant activity of the APCC FEIBA. Factor II, factor VII, factor IX, and factor X were reduced in platelet-poor plasma, and the thrombin potential (TP) was determined using a chromogenic substrate in the absence or presence of FEIBA. Reduction of factor II resulted in a significant decrease of the TP without influencing the lag phase until the onset of thrombin generation. The reduction of factor VII showed no effect on the TP, but resulted in a prolongation of the lag phase. Changes of factor IX or factor X concentrations showed neither an effect on the TP nor on lag phases. Our study demonstrates that thrombin generation in the presence of FEIBA mainly depends on prothrombin.
Find related publications in this database (using NLM MeSH Indexing)
Blood Coagulation Factors - pharmacology
Factor IX - physiology
Factor VII - physiology
Factor X - physiology
Hemostasis - drug effects
Humans - drug effects
Prothrombin - physiology
Thrombin - biosynthesis
Thrombophilia - biosynthesis

Find related publications in this database (Keywords)
activated prothrombin complex concentrates
thrombin generation
© Med Uni Graz Impressum